These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36526818)

  • 1. Effects of MRI on stemness properties of Wharton's jelly-derived mesenchymal stem cells.
    Tashakori M; Asadi F; Khorram FS; Manshoori A; Hosseini-Chegeni A; Moghadam FM; Kamalabadi MA; Yousefi-Ahmadipour A
    Cell Tissue Bank; 2023 Sep; 24(3):523-533. PubMed ID: 36526818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
    Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
    Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold-free 3D culturing enhance pluripotency, immunomodulatory factors, and differentiation potential of Wharton's jelly-mesenchymal stem cells.
    Thakur G; Bok EY; Kim SB; Jo CH; Oh SJ; Baek JC; Park JE; Kang YH; Lee SL; Kumar R; Rho GJ
    Eur J Cell Biol; 2022; 101(3):151245. PubMed ID: 35667339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
    Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
    Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
    Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
    Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB; Bharti D; Subbarao RB; Jang SJ; Park JS; Ullah I; Park JK; Byun JH; Park BW; Rho GJ
    J Cell Biochem; 2016 Oct; 117(10):2397-412. PubMed ID: 27038129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
    Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
    Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
    Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
    Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration.
    Panwar U; Mishra K; Patel P; Bharadva S; Vaniawala S; Shah A; Vundinti BR; Kothari SL; Ghosh K
    Cells Tissues Organs; 2021; 210(4):239-249. PubMed ID: 34521091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from human umbilical cord: gender differences in stem cells from Wharton's jelly.
    Balzano F; Bellu E; Basoli V; Dei Giudici S; Santaniello S; Cruciani S; Facchin F; Oggiano A; Capobianco G; Dessole F; Ventura C; Dessole S; Maioli M
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():143-148. PubMed ID: 30690190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton's Jelly.
    Sypecka M; Bzinkowska A; Sulejczak D; Dabrowski F; Sarnowska A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Proteomic Analysis Identifies EphA2 as a Specific Cell Surface Marker for Wharton's Jelly-Derived Mesenchymal Stem Cells.
    Al Madhoun A; Marafie SK; Haddad D; Melhem M; Abu-Farha M; Ali H; Sindhu S; Atari M; Al-Mulla F
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
    Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.
    Musiał-Wysocka A; Kot M; Sułkowski M; Badyra B; Majka M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.